CA
NZ
UK
AU
IND
US
● VTEX shares closed at $3.74 on August 14, 2026, down roughly 1.8% that day, near the bottom of their 52-week range.
● Zentalis Pharmaceuticals shares fell roughly 6.5% in after-hours trading following a dilutive share offering.
● Usio shares rose roughly 6.7% during the August 13 session, breaking above their prior 52-week high of $2.62.
● VinFast Auto shares have been drifting higher in recent sessions, trading around $3.17 as of August 14, 2026.
● The company reported aRevenuebeat, a positive operational signal overshadowed by other concerns.
● Second-quarter results showed a swing to net profit, a significant milestone for the office landlord.
● Prime Medicine is a Cambridge, Massachusetts-based gene-editing biotech built around Prime Editing, a precision DNA-rewriting technology.
● Rocket Pharmaceuticals is a commercial-stage gene-therapy company built around treatments for ultra-rare genetic diseases.
● The company rejected a $5.25Takeoverbid, choosing to remain independent.
● The company achieved a GenentechPartnershipmilestone, a positive development overshadowed by broader cash burn concerns.
Please wait processing your request...